小儿急性期脑膜炎球菌性脑膜炎：需要花费多少？
Pediatric meningococcocal meningitis in the acute phase: how much does it cost?
机构信息
Pediatric and Infectious Disease Unit, Bambino Gesù Children Hospital, Rome, Italy.
Sanitary Direction, Bambino Gesù Children Hospital, Rome, Italy.
出版信息
Ital J Pediatr. 2019 Feb 13;45(1):25. doi: 10.1186/s13052-019-0616-z.
BACKGROUND
Meningococcal meningitis (MM) is known to be responsible of high cost for the Public Health Administration. Aim of the work is to calculate the costs for the hospitalization of pediatric patients affected by MM.
METHODS
We calculate the costs for the hospitalization of pediatric patients affected by MM in the acute phase (HAP) over a nine year period. We performed a MEDLINE search to verify the cost of MM HAP reported in other studies.
RESULTS
At Bambino Gesù Children Hospital, the median cost of HAP was of 12,604 euro (range from 9203 to 35,050 euro). Comparing our data with the previous studies, we find out similar results of approximately 16,750 euro (range 12,000-20,000 euro).
DISCUSSION
Despite the relative rarety of the disease, MM is associated to direct high cost of HAP.
CONCLUSIONS
Hospital costs are an important end-point in health economic evaluation of the disease and may be useful to policy makers and health economists to understand the potential benefit of improving meningococcal vaccination programmes.
背景
脑膜炎奈瑟菌（脑膜炎球菌）性脑膜炎（MM）已知会给公共卫生管理带来高昂成本。本研究旨在计算患有 MM 的儿科患者住院治疗的费用。
方法
我们计算了 9 年内患有 MM 的儿科患者在急性期（HAP）住院的费用。我们进行了 MEDLINE 检索，以验证其他研究中报告的 MM HAP 的成本。
结果
在 Bambino Gesù 儿童医院，HAP 的中位数费用为 12604 欧元（范围为 9203 至 35050 欧元）。将我们的数据与之前的研究进行比较，我们发现大约为 16750 欧元（范围为 12000-20000 欧元）的相似结果。
讨论
尽管这种疾病相对罕见，但 MM 与 HAP 的直接高成本相关。
结论
医院费用是疾病卫生经济学评估的一个重要终点，对于政策制定者和卫生经济学家来说，了解改善脑膜炎球菌疫苗接种计划的潜在收益可能是有用的。
Zotero 插件